Extrovis AG

Extrovis is a global pharmaceutical company based in Switzerland with subsidiaries in Hungary and India. The Indian unit employs 60 scientists and researchers focused on developing complex APIs and finished dosage forms for pharmaceutical products. The company has established a presence in Hungary to support its plans for entering the European market and employs a team for supply chain, regulatory, pharmacovigilance and customer service. Extrovis' portfolio includes niche generic products, products with formulation improvements, and redesigned products for patient safety and convenience, mostly as drug-device combinations.